Detalhe da pesquisa
1.
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
N Engl J Med
; 390(9): 795-805, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962077
2.
Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.
Acta Derm Venereol
; 95(1): 57-61, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682319
3.
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.
CNS Spectr
; 14(3): 144-54, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19407711
4.
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.
Int Clin Psychopharmacol
; 23(5): 243-53, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18703933
5.
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder.
Int Clin Psychopharmacol
; 23(4): 188-97, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18545056
6.
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Int Clin Psychopharmacol
; 22(6): 338-47, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17917552
7.
Poster 292 Improvement of Spasticity Following AbobotulinumtoxinA (Dysport®) Injections in Shoulder Muscles in Hemiparetic Patients with Upper Limb Spasticity-Sub-Analysis of a Prospective, Long-Term, Open-Label Study with Single and Repeated Injection Cycles.
PM R
; 8(9S): S255, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27673048